SHR-9839(sc)

SHR-9839 · Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-9839(sc), covering 2026-03-20 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A IB/II Phase Clinical Study on the Safety, Tolerability, and Efficacy of SHR-9839(sc) in Combination Anti-tumor Therapy in Patients With Solid Tumors [Phase 1, Phase 2]

See pricing